Company: DARE
Filing Date: 2025-08-14
Form Type: 10-Q
Source: 0001401914-25-000044
Chunk: 16

Company: Dare Bioscience, Inc.
Filing Date: 2025-08-14
Form: 10-Q
Item: Part II, Item 3
Chunk 16
---
 Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

Daré Bioscience, Inc.Date: August 14, 2025By:/s/ Sabrina Martucci JohnsonSabrina Martucci JohnsonPresident and Chief Executive Officer(Principal Executive Officer and Principal Financial Officer)Date: August 14, 2025By:/s/ MarDee Haring-LaytonMarDee Haring-LaytonChief Accounting Officer(Principal Accounting Officer)

50